QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 eli-lilly-novo-nordisk-make-weight-loss-drugs-more-affordable-via-medicare-medicaid-trumprx

The Trump administration struck deals with Eli Lilly and Novo Nordisk to lower obesity drug prices and expand Medicare coverage...

 ai-stocks-slide-again-bitcoin-dips-near-100000-whats-moving-markets-thursday

After a brief and cautious rebound on Wednesday, risk-off sentiment returned sharply on Thursday, with AI-linked stocks leading...

 astrazeneca-calms-pricing-jitters-says-us-deal-hit-absorbable

AstraZeneca's Q3 sales rose 12% to $15.19 billion, beating forecasts as cancer and biopharma growth lifted results; 2025 gu...

Core News & Articles

Axsome Therapeutics, Inc. (NASDAQ:AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous syst...

 astrazeneca-q3-adj-eps-119-beats-114-estimate-sales-15191b-beat-14805b-estimate

AstraZeneca (NASDAQ:AZN) reported quarterly earnings of $1.19 per share which beat the analyst consensus estimate of $1.14 by 4...

 snowflake-and-sap-bridge-enterprise-data-silos-in-major-ai-integration-push

Snowflake Inc. & SAP SE collaborate to integrate their AI and business data clouds, providing faster access to reliable dat...

Core News & Articles

-Reuters

 astrazeneca-daiichi-sankyos-datroway-showed-statistically-significant-clinically-meaningful-improvement-for-dual-primary-endpoints-of-overall-survival-progression-free-survival-in-tropion-breast02-phase-3-study-for-recurrent-inoperable-or-metastatic-triple-negative-breast-cancer

Positive results from the TROPION-Breast02 Phase III trial showed DATROWAY® (datopotamab deruxtecan-dlnk) demonstrated a statis...

Core News & Articles

https://www.bloomberg.com/news/articles/2025-10-28/us-fires-top-health-official-who-opposed-widely-used-covid-shots?srnd=homepa...

 the-european-agency-recommends-approving-astrazenecas-saphnelo-as-self-administered-once-weekly-pre-filled-pen-for-systemic-lupus-erythematosus-on-top-of-standard-therapy-8k

The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency based its positive opinion on interi...

Core News & Articles

AstraZeneca and Daiichi Sankyo's DATROWAY also demonstrated a highly statistically significant and clinically meaningful 43...

Core News & Articles

Approval Broadens Indication for TEZSPIRE to a Second Disease Characterized by Epithelial-Driven Inflammation

 invo-fertility-stock-is-plunging-after-white-house-announcement

INVO Fertility Inc (NASDAQ:IVF) shares are trading lower on Thursday as investors book profits following White House announceme...

 tropion-pantumor03-phase-2-trial-shows-that-datroway-jointly-developed-and-commercialized-by-daiichi-sankyo-and-astrazeneca-reveals-promising-tumor-responses-in-patients-with-metastatic-urothelial-cancer-in-tropion-pantumor03-phase-2-trial-a-confirmed-objective-response-rate-of-682-and-a-disease-control-rate-of-955-was-observed-in-previously-untreated-cisplatin-ineligible-patients

Initial results from one sub-study of the TROPION-PanTumor03 phase 2 trial showed that DATROWAY® (datopotamab deruxtecan) plus ...

 astrazeneca-shares-matterhorn-phase-iii-trial-results-for-patients-treated-with-neoadjuvant-imfinzi-in-combination-with-chemotherapy-before-surgery-followed-by-adjuvant-imfinzi-in-combination-with-chemotherapy-then-imfinzi-monotherapy

More than two thirds of patients treated with IMFINZI-based perioperative regimen were alive at three yearsFirst and only perio...

 uk-finance-minister-seeks-more-pharma-investment-in-exchange-for-higher-drug-prices-report

UK finance minister Rachel Reeves told reporters that the country needs to be an attractive place for pharma, including in term...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION